Researchers plan to present their findings from the preliminary study at the upcoming AAN meeting in Chicago next month, the organization says
This review aims to synthesize current evidence on the molecular mechanisms and therapeutic potential of FGF21 in metabolic dysfunction-associated steatohepatitis
These GLP-1 medications are revolutionizing obesity care but how soon can you expect to see results
doi:10.1210/clinem/dgz140 Grandone A, Di Sessa A, Umano GR, Toraldo R, Miraglia Del Giudice E
Recognized adverse effects include cholelithiasis, gastrointestinal disturbances, and reductions in lean mass [10,11,12]
The dosing follows a specific titration schedule: starting with 2.5 mg once weekly for 4 weeks as an initiation dose, then increasing to 5 mg